Pennsylvania And Melbourne

Interim Results From Mesoblast's Phase 2 Heart Failure Trial Shows 'Off-the-Shelf' Proprietary Adult Stem Cell Product Revascor(TM) Reduces Cardiac Events, Mortality, and Hospitalization

FRAZER, Pennsylvania and MELBOURNE, Australia, January 10, 2011 - Cephalon, Inc.